Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 14 , ISSUE 5 ( September-October, 2022 ) > List of Articles

CASE REPORT

Challenging Management for Pregnancy and Delivery in Women with Achondroplasia and Pesudoachondroplasia

Adityo Prabowo, Khanisyah Erza Gumilar

Keywords : Achondroplasia, Autosomal dominant, Cartilage oligomeric matrix protein, Fibroblast growth factor receptor 3, Pregnancy, Pseudoachondroplasia, Short stature

Citation Information : Prabowo A, Gumilar KE. Challenging Management for Pregnancy and Delivery in Women with Achondroplasia and Pesudoachondroplasia. J South Asian Feder Obs Gynae 2022; 14 (5):616-618.

DOI: 10.5005/jp-journals-10006-2125

License: CC BY-NC 4.0

Published Online: 16-11-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Background: Achondroplasia is a rare genetic disease of bone growth with an incidence of 1:20,000 live births which is characterized by short stature disproportionate body, shortening of long bones, macrocephaly, and kyphoscoliosis. While pseudoachondroplasia is caused by an autosomal dominant mutation in the cartilage oligomeric matrix protein (COMP). Due to the rarity of this condition and its adverse impact on the obstetrical outcome, we find it interesting to report two cases of achondroplasia and pseudoachondroplasia with pregnancy. Case description: The first case was a 24-year-old woman with achondroplasia (patient's height was 116 cm) primigravida, who was referred at her 36–37 weeks of gestation. Ultrasound examination of the fetus revealed micromelia skeletal dysplasia. At 37–38 weeks of gestation, the patient underwent a cesarean section under the subarachnoid block (SAB) regional anesthesia because of the complication of cephalopelvic disproportion (CPD). The baby had a relatively large head circumference, frontal bossing, disproportionate short limbs, and trident hand appearance which is pathognomonic of achondroplasia. The second case was a 26-year-old woman with pseudoachondroplasia (patient's height was 127 cm) multigravida with a history of one abortion, who was referred at her 35–36 weeks of gestation. The patient underwent elective cesarean section with SAB regional anesthesia and the baby looked physically not inheriting maternal abnormalities. Conclusion: Achondroplasia increases maternal and fetal obstetric complications; thus, requiring prenatal counseling, comprehensive risk evaluation, and multidisciplinary team management of anesthesia, obstetrics, and neonatology.


PDF Share
  1. Pauli RM. Achondroplasia: A comprehensive clinical review. Orphanet J Rare Dis 2019;14(1):1. DOI: 10.1186/s13023-018-0972-6.
  2. Weinstein SL, Flynn JMF, Crawford HA. The skeletal dysplasias. In: Lovell and Winter's: Pediatric Orthopaedics, 8th edition, Vol. 1. Philadelphia: Lippincott Williams and Wilkins, 2002, pp.214–258.
  3. Cunningham FG, Leveno KJ, Bloom SL, et al. Maternal physiology. In: Williams Obstetrics, 25th edition. New York: McGraw-Hill Education, 2018, p.49–79.
  4. Melekoglu R, Celik E, Eraslan S. Successful obstetric and anaesthetic management of a pregnant woman with achondroplasia. BMJ Case Rep 2017; 2017:bcr-2017-221238. DOI: 10.1136/bcr-2017-221238.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.